- Home
- Services
- usa pennsylvania
- clinical linked data
Refine by
Clinical Linked Data Services In Usa Pennsylvania
5 services found
by:Managed Markets Insight & Technology, LLC (MMIT) based inYardley, PENNSYLVANIA (USA)
Exposing potential obstacles through market research with unbiased and objective insights from P&T decision-makers is critical. MMIT P&T Perspectives provides qualitative and tangible feedback through a realistic simulated P&T session that informs your individual brand strategy and enables you to understand how your product and/or competitor’s product will fare in an actual ...
by:Managed Markets Insight & Technology, LLC (MMIT) based inYardley, PENNSYLVANIA (USA)
MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready ...
by:Strados Labs based inPhiladelphia, PENNSYLVANIA (USA)
Beyond Cough Count: RESP Cough Trial Solution (CTS) optimizes chronic cough trials to better capture lung sound biomarkers. RESP allows clinical endpoints for coughs to be captured and show positive results. A portion of these positive results revolve around being able to differentiate between voluntary coughs vs. involuntary coughs to determining if the drug is working as planned. RESP makes ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of radiopharmaceuticals requires a partner that has extensive ...